Peninsula biotech adds space exactly where it needed it: ‘We just didn’t have enough room’


The FDA would decide whether its cancer cell therapy is approved, perhaps by the first half of next year.

Previous UO undergraduate research fosters biotech’s next generation of workers
Next Hawaii Department of Health receives $3.5M to establish behavioral health center